Borenius‘ IP practice spans the pharmaceutical, medical technology, and healthcare sectors, where the team assists clients with non-contentious regulatory issues, trademark portfolio management, and data economy matters. The team also covers IP litigation related to unfair business practices, trade secrets, copyright and related rights, as well as alternative dispute resolution and arbitration proceedings. The practice is under the joint leadership of Lasse Laaksonen, who has extensive IP-related arbitration experience, and Ben Rapinoja, who specialises in pharmaceutical, healthcare, and high-tech sector transactional arrangements. Saara Lapiolahti is involved in litigation cases concerning pharmaceutical patents and copyright, while Jemina Bonsdorff is a key contact for cases held before the Finnish Market Court and Supreme Court. Wilma Kivilä covers the full spectrum of IP and technology matters.
Legal 500 Editorial commentary
Accolades
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- 'Lasse Laaksonen has excellent skills in planning a strategy for every step of the trademark life cycle.'
- 'Top-notch pharmaceutical patent litigation advice.'
- 'Borenius' team combines high-end legal practice with a state-of-the-art trademark attorney practice in a client-friendly manner.'
Key clients
- Teva B.V.
- Teva Finland Oy
- Stada Arzneimittel AG
- Generics (U.K.) Ltd
- Lumene Ltd
- Soda-Club (CO2)
- SodaStream International B.V.
- Harvia Plc
- AB Enzyme Oy
- OptiWatti Oy
- Detection Technology Plc
Work highlights
Successfully represented Mylan Ireland Limited and Viatris Oy in a preliminary injunction case related to Biogen’s patent concerning dimethyl fumarate (Biogen’s brand name Tecfidera®), where the Market Court dismissed Biogen’s application for preliminary injunction as Viatris had sufficiently challenged the presumption of validity of the patent-in-suit.
Represented AB Enzymes Finland Oy, a subsidiary of Associated British Foods, in pending employment invention compensation proceedings at the Market Court concerning inventors' alleged further rights for compensation for patented inventions amounting to over 20 million euros.
Represented Soda-Club (CO2) and SodaStream International B.V. in a trademark infringement dispute against MySoda before the Market Court and Supreme Court, where the case was referred to the CJEU for a preliminary ruling on trademark exhaustion (C-197/21), resulting in SodaStream successfully obtaining compensation and damages from MySoda.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Ben Rapinoja; Lasse Laaksonen
Other key lawyers
Saara Lapiolahti; Jemina Bonsdorff; Wilma Kivilä